Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-16

Clinical Trial Update: Study to Confirm the Efficacy and Safety of Fixed-dose Combinations of Amlodipine and Candesartan [Phase 4]

View source ↗

Summary

A Phase 4 trial assessing the efficacy and safety of fixed-dose combinations of amlodipine and candesartan for hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • amlodipine and candesartan fixed-dose combination (amlodipine; candesartan)

Snippet

Sponsor: HK inno.N Corporation | Conditions: Hypertension | Phase 4 | Status: UNKNOWN